Recording and measuring the outcome of an ART cycle

Similar documents
ANZARD 2.0 Data Dictionary V2

Regulation of ART. S.T.A.R.T. Melbourne, 19 th February, 2017

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

CODE OF PRACTICE FOR ASSISTED REPRODUCTIVE TECHNOLOGY UNITS INTERNATIONAL EDITION. Fertility Society of Australia

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Tammie Roy Genea Biomedx Sydney, Australia. Declared to be stakeholder in Genea Biomedx

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

From Analytics to Action

Independent Review of Assisted Reproductive Technologies

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome

European IVF Monitoring (EIM) Year: 2013

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

BJA Performance Measures

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

GYNEM PRICELIST 2018

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Assisted Reproductive Technologies

Preimplantation Genetic Diagnosis (PGD) in Western Australia

*Correspondence address.

SOUTHEND CENTRES FERTILITY CLINICS. FOR APPOINTMENTS CALL , DELHI

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Blastocyst culture at The Bridge Centre London. Shaun Rogers Laboratory Manger

The Age of ART cont. The ART of Donation

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Poster Session HRT1317 Innovation Awards November 2013 Brisbane

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

Fertility Tourism. Dr Karen Buckingham. National Women s Annual Clinical Report Day August 2013

INFERTILITY SERVICES

European IVF Monitoring (EIM) Year: 2012

Bumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.

KENT BISHOP M.D. ProMedica Chief Experience Officer President Women s Service Line

Understanding IVF Processes in Surrogacy

Sleep Market Panel. Results for June 2015

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

Kansas EMS Naloxone (Narcan) Administration

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

(revised March 2014)

IVF. NHS North West London CCGs

EGG FREEZING FOR SOCIAL REASONS. P. Patrizio, M.D., MBE, HCLD Yale University Fertility Center New Haven, CT-USA

Your consent to the storage of your eggs or sperm

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction

A guide to choosing the right fertility clinic. 12 questions to ask when researching your options

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

Blue Distinction Centers for Fertility Care 2018 Provider Survey

FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018

Research Licence Renewal Inspection Report

Health Equity Workgroup. January 18, 2018

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

International Federation of Fertility Societies. Global Standards of Infertility Care

My VeriSTAR & Veristar Info: The all-in-one portal for Marine professionals

Patient Information: Frozen Donor Eggs

The 5th World congress of the INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION Vienna, Austria November 16-18, 2017

ManorIVF Donor Egg Service to Australia

Evolution of IVF past, present and future with focus on the laboratory

RAH s Regional Fertility & Women s Endocrine Clinic FAQs

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

AUCKLAND REGIONAL ALCOHOL FORUM. 2 June 2011

Advice on Aspects of Assisted Reproductive Technology:

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Assisted Reproductive Technology National Summary Report Belgium 2015

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Abstract. Introduction. Materials and methods. Patients and methods

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

Consultation and Investigations

your guide to egg freezing Clinical excellence & bespoke fertility care

Infertility treatment

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Reproductive Technology, Genetic Testing, and Gene Therapy

Global In-Vitro-Fertilization Market: Trends and Opportunities ( )

McLean ebasis plus TM

r e p r o d u c t i v e b i o l o g y x x x ( ) x x x x x x Available online at ScienceDirect

Schedule of Fees for Private Treatment

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Fertility Services Commissioning Policy

Men s consent to the use and storage of sperm or embryos for surrogacy

Number of oocytes and live births in IVF

CONSENT FOR CRYOPRESERVATION OF EMBRYOS

Quit Rates of New York State Smokers

Family Building Through Use of DONATED EMBRYOS. Robin L. Poe-Zeigler, MD, FACOG

An Updated Approach to Colon Cancer Screening and Prevention

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Vitrification: "Robots" versus Human Comparing automated vitrification outcomes

Prof. Antonio Pellicer

Invisalign Education Course Booklet 2018

Transcription:

Recording and measuring the outcome of an ART cycle Australian and New Zealand Reproduction Database (ANZARD) Dr Katie Harris Biostatistician National Perinatal Epidemiology and Statistics Unit (NPESU) katie.harris@unsw.edu.au

Outline of presentation Australian and New Zealand Assisted Reproduction Database (ANZARD) History Structure and scope Data collection and validation Updates Reporting Research

History of ANZARD Assisted Conception Data Collection (ACDC) 1979 2001 Contains pregnancy and birth outcomes following ART treatment Australian and New Zealand Assisted Reproduction Database (ANZARD) 2002 2008 Includes treatment cycles and pregnancy outcomes

ANZARD2.0 2009 present All ART treatment cycles in Australia and New Zealand 40 fertility centres (83 clinics in Aus & 8 in NZ) Link treatment cycles for same patient using statistical linkage key First two letters of first name and surname & Date of Birth Each row of data is a cycle Annually: 70,000 cycles, 37,000 Women 94 Data Items ANZARD3.0 coming soon

Scope of ANZARD

Structure of ANZARD Patient demographics Name code, age, parity, cause of infertility, postcode Treatment procedures Fertilisation: IVF, ICSI, GIFT PGD (preimplantation genetic diagnosis) Embryo transfer: Cleavage, Blastocyst, SET, DET Cryopreservation: Slow frozen, vitrified Donation and recipient cycles: Oocytes, embryos Outcomes Clinical pregnancy: Live delivery, early pregnancy loss Birth outcomes: Sex, gestational age, birthweight, plurality, Perinatal mortality

Purpose of ANZARD Monitoring the safety and quality of ART treatment Informing clinical practice Providing evidence through annual reporting and research for policy development Conducting research and international comparison

Data submission and 2015 report timeline 2015 data submitted Cycles 1 st Jan 2015 31 st Dec 2015 Deliveries up to 31 st Oct 2016 Australia and New Zealand feedback report release 2015 ART report published Oct 2016 Nov 2016 Dec 2016 Jan 2017 Feb 2017 Mar 2017 Apr 2017 May 2017 Jun 2017 Jul 2017 Aug 2017 Sep 2017 Oct 2017 NPESU validates and finalises data 2015 ART report produced

Upgrading ANZARD Updating validation program Clinics upload data via a secure web portal Manual entry form Batch upload Real-time validation Update database management and analysis system SQL R Modify system used by the Australian and New Zealand Neonatal Network (ANZNN)

ANZNN Data capture system - https://anznn.med.unsw.edu.au/ Information - https://anznn.net/dataresources/datacapturesystem

Benefits of new system Much better for clinics - Easy navigation and user friendly interface Two levels of user accounts Timely validation and feedback procedure Offers transparency in validation process Streamline production of feedback reports

ANZARD3.0 Data items Opportunity to remove / include data items Remove Transportation cycles (Import, export, disposal) Include Height, Weight, Same sex and single parent family indicator, PGD or PGS, treatment type Improve next slide

Items for improved reporting Stim_1st Important due to use in defining a first cycle within ANZARD Reliant on patient reporting Causes confusion where there is an OPU cancellation Preg_20w Reliant on patient reporting All cause of infertility variables Ongoing medical journey of patient makes it difficult to validate this variable at a patient level Should ANZARD be checking for consistency within a patient or assume diagnosis can change over time? Name and date of birth details Important due to use in linking cycles Slight data entry errors can cause difficulty in linking cycles (e.g. DOB changing by one digit) Some changes in name are unavoidable, e.g. after marriage Validation process now uses pat_id to ensure that name and fdob are as consistent as possible within a data submission PR_CLIN If a clinical pregnancy is recorded then the date pregnancy ended (PR_END_DT) must be completed

Reporting Overview of ART treatment Autologous and donation/recipient cycles Pregnancy and birth outcomes following autologous/recipient cycles Other cycle types, procedures and treatment complications Trends in ART treatment and outcomes Linking and follow up of women and cycles

Tables and Figures from 2014 ANZARD report

91.1% 13.7% 65.0% 19.8% 15.3%

93.6% 30.9% 23.6%

Different rates

Live delivery among fertility centres

Other procedures Gestational surrogacy cycles Preimplantation genetic diagnosis Assisted hatching Gamete intrafallopian transfer Ovarian hyperstimulation syndrome

Slow frozen cleavage stage Vitrified cleavage stage Vitrified blastocyst

Cycle specific live delivery rates

Research projects Cumulative live birth rates Method for assessing variation in clinic success rates Socio-economic disparities in access to assisted reproductive technologies in Australia Health economics

National Perinatal Epidemiology and Statistics Unit (NPESU) ANZARD team Dr Katie Harris Mr Oisin Fitzgerald Mr Repon Paul A/ Prof Georgina Chambers

Acknowledgements Thank you to the Australia and New Zealand fertility centres for the provision of the ANZARD data. Katie Harris Tel: 02 9385 9462 Email: Katie.harris@unsw.edu.au ANZARD Team: ANZARD@unsw.edu.au Report available: http://npesu.unsw.edu.au